Form 4: Algorhythm Holdings Executive Adjusts Stock Options

Sentiment:

Statement of Changes in Beneficial Ownership


Algorhythm Holdings CFO & General Counsel Andre Alex has modified his stock option holdings, canceling existing awards and receiving new ones under the company's incentive plan.

Summary

  • Andre Alex, CFO & General Counsel of Algorhythm Holdings, Inc., reported changes to his beneficial ownership of company stock on May 11, 2026.
  • The transaction involved the cancellation of a previously granted restricted stock award for 23,818 shares.
  • Additionally, a non-qualified stock option to purchase 23,818 shares was canceled.
  • In replacement, Alex received a new non-qualified stock option to purchase 47,636 shares, granted under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
  • The new options have a vesting schedule: 25% vest on the first anniversary of the grant date, with the remaining shares vesting in quarterly increments of 6.25% thereafter.
  • A portion of the new options, 14,636 shares, vested immediately on the grant date, with subsequent quarterly vesting of 3,666.667 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While it involves executive compensation adjustments, the cancellation of existing awards and issuance of new ones is a routine event for insiders and does not inherently signal positive or negative performance.

Positives

  • The CFO & General Counsel received new stock options, indicating continued incentive alignment with the company's performance.
  • A significant portion of the new options (14,636 shares) vested immediately, providing immediate benefit.
  • The company has an established equity incentive plan (2022 Equity Incentive Plan) to reward key personnel.

Negatives

  • Existing stock awards and options were canceled, which could imply a restructuring of executive compensation or a change in the perceived value of prior grants.
  • The cancellation of existing awards without immediate replacement of equivalent value could be viewed negatively if the new grants are less favorable.

Risks

  • The cancellation of previously granted equity awards could signal internal concerns or a reassessment of executive compensation strategies.
  • The vesting schedule for the new options means that the full benefit is not realized immediately, creating a retention incentive but also a potential point of concern if the executive departs before full vesting.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on a change in beneficial ownership of securities.

Management Comments

  • The transaction involved the cancellation of previously granted awards and the receipt of new options under the company's equity incentive plan.
  • Specific vesting details for the new options are provided, indicating a phased approach to equity realization.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting changes in beneficial ownership by company insiders. The modification of stock options by a CFO is a common occurrence, often tied to annual compensation reviews or strategic adjustments to incentive structures within the technology and software sectors where Algorhythm Holdings operates.

Stakeholder Impact

  • Shareholders: The adjustment in executive compensation through stock options is a standard practice and typically has a neutral immediate impact, though it can influence long-term alignment and retention.
  • Employees: The existence of an equity incentive plan signals a broader approach to employee motivation and retention, though this specific transaction pertains to a senior executive.
  • Management: The CFO's compensation is being adjusted, reflecting ongoing performance and retention strategies.

Next Steps

  • The new stock options will vest according to the schedule outlined: 25% on the first anniversary of the grant date, followed by 6.25% vesting quarterly thereafter.
  • Continued monitoring of subsequent Form 4 filings from Andre Alex and other insiders will provide further insight into their confidence and investment in Algorhythm Holdings.

Key Dates

DateDescription
05/11/2026Earliest transaction date and date of stock option transactions.
02/23/2036Expiration date for the stock option to purchase 23,818 shares.
05/11/2036Expiration date for the new stock option to purchase 47,636 shares.
05/13/2026Date of signature on the filing.

Keywords

Form 4, SEC Filing, Algorhythm Holdings, RIME, Stock Options, Equity Incentive Plan, Beneficial Ownership, CFO, General Counsel, Insider Trading, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.